Brief: Galectin Therapeutics Announces Publication Of Navigate Phase 2B Trial Results For Belapectin In The Journal Of Hepatology
11/05/2026 13:55
May 11 (Reuters) - Galectin Therapeutics Inc GALT.O: GALECTIN THERAPEUTICS ANNOUNCES PUBLICATION OF NAVIGATE PHASE 2B TRIAL RESULTS FOR BELAPECTIN IN THE JOURNAL OF HEPATOLOGY Source text: ID:nGNXbQQpx7 Further company coverage: GALT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study